Immunodiagnostics Market Scope And Analysis

Report Code : TIPRE00003722
Category : Life Sciences

Status : Published
No. of Pages : 270

Buy Now

Immunodiagnostics Market Analysis Report 2023 to 2030

Buy Now

Immunodiagnostics Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 19.22 Billion
Market Size by 2030	US$ 34.49 Billion
Global CAGR (2022 - 2030)	7.6%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Product Enzyme-Linked Immunosorbent Assays Chemiluminescence Immunoassays Radioimmunoassays By Clinical Indication Infectious Diseases Hepatitis+HIV Endocrinology Gastrointestinal Metabolics By End User Hospitals Clinics Diagnostic Laboratories Academic & Research Institutes
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Laboratories F Hoffmann La Roche Ltd DiaSorin SpA Danaher Corporation Thermo Fisher Scientific Inc PerkinElmer Inc Shenzhen Mindray Bio Medical Electronics Co Ltd bioMerieux SA Svar Life Science AB

Key Player Analysis:

The immunodiagnostics market majorly consists of players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Danaher Corp, Thermo Fisher Scientific Inc, PerkinElmer Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, bioMerieux SA, Svar Life Science AB, and Siemens Healthineers AG.

Abbott Laboratories and F. Hoffmann-La Roche Ltd are the top two players in the immunodiagnostics market. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. On the flip side, inorganic strategies, such as product launches, partnerships, and collaborations, were widely seen in the immunodiagnostics market.

Recent Developments:

Inorganic and organic strategies are highly adopted by companies in the immunodiagnostics market. A few recent key market developments are listed below:

In April 2023, Thermo Fisher Scientific announced a partnership with ALPCO-GeneProof, a global leader in diagnostics. The partnership has helped in bringing TaqPath Menu | GeneProof PCR kits into the market.
In July 2022, Abbott Diagnostics announced its participation in American Association for Clinical Chemistry (AACC) 2022. In the exhibition, the company demonstrated its diagnostics systems and analyzers.
In May 2023, Thermo Fisher Scientific announced that the US FDA had cleared its immunoassays, B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR novel biomarkers. These immunoassays assess risks and clinical management of preeclampsia, a severe pregnancy complication.